**Core Concept**
HPV (Human Papillomavirus) is a significant risk factor for cervical malignancy, with certain types being more strongly associated with cancer development than others. The HPV virus infects the cervix and can lead to the development of cervical intraepithelial neoplasia (CIN), which can progress to invasive cervical cancer.

**Why the Correct Answer is Right**
HPV types 6 and 11 are primarily associated with low-grade cervical lesions and genital warts, whereas HPV types 16 and 18 are responsible for approximately 70% of all cervical cancers. These high-risk types integrate into the host genome, leading to the disruption of cell cycle regulation and the development of malignant transformation. In contrast, HPV types 6 and 11 are considered low-risk and are less likely to cause significant malignant changes.

**Why Each Wrong Option is Incorrect**
**Option B:** Incorrect because HPV type 31 is a high-risk type associated with cervical cancer, although not as strongly as types 16 and 18.
**Option C:** Incorrect because HPV type 33 is also a high-risk type linked to cervical malignancy, although its association is weaker than that of types 16 and 18.

**Clinical Pearl / High-Yield Fact**
The bivalent HPV vaccine (Cervarix) targets types 16 and 18, providing protection against approximately 70% of all cervical cancers. The quadrivalent HPV vaccine (Gardasil) targets types 6, 11, 16, and 18, providing protection against a broader range of cervical and other anogenital cancers.

**Correct Answer:** D.